← Leaderboards
Jacqueline Carozza
Stanford University
$104,073
Attributed
$104,073
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.5K · FY2019–21$50K$37.5K$25K$12.5K$0
'19
'20
'21
Funding mix
By agency
NIH$104,073 · 1
By mechanism
F31$104,073 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Steven E Artandi$26,596,623
- Bryan Sun$5,464,263
- Alexander D Boiko$3,037,060
- Yunyan Jennifer Jennifer Zhang$7,749,335
- Kari C. Nadeau$30,132,783
Others in their field
Other Emerging Leaders on “Cancer Therapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$71,892,510
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$65,177,437
- Martha Hering · Westat, Inc.$57,098,843
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
Cancer TherapyAdaptive Immune ResponseBiochemicalAnalogAnti-CancerBindingAdaptive Immune SystemBiologicalBiologyCancer CellCancer Cell LineCancer ImmunotherapyCancer PatientActive SitesCarrier ProteinsCell Culture TechniquesCellsChromosomal InstabilityCrispr ScreenCyclic GmpCytokineCytosolDesignAchievement
Grant awards (3)
Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy$13,537
F31 · FY2021 · CA · contact PI
Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy$45,520
F31 · FY2020 · CA · contact PI
Harnessing the innate immunotransmitter cGAMP for anti-cancer therapy$45,016
F31 · FY2019 · CA · contact PI